• Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer
  Catalog No.:AP0063        Pubmed No.:37295240        PMCID:
  Details:
  Journal name:
• Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer
  Catalog No.:AP0153        Pubmed No.:37295240        PMCID:
  Details:
  Journal name:
• Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer
  Catalog No.:BS1392        Pubmed No.:37295240        PMCID:
  Details:
  Journal name:
• Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer
  Catalog No.:BS1820        Pubmed No.:37295240        PMCID:
  Details:
  Journal name:
• Paeoniae Radix Rubra extract attenuates cerebral ischemia injury by inhibiting ferroptosis and activating autophagy through the PI3K/Akt signalling pathway
  Catalog No.:AP0060        Pubmed No.:37172921        PMCID:
  Details:
  Journal name:
• An integrated network pharmacology approach reveals that Darutigenol reduces inflammation and cartilage degradation in a mouse collagen-induced arthritis model by inhibiting the JAK-STAT3 pathway
  Catalog No.:ZJ2020-R        Pubmed No.:37160212        PMCID:
  Details:
  Journal name:
• An integrated network pharmacology approach reveals that Darutigenol reduces inflammation and cartilage degradation in a mouse collagen-induced arthritis model by inhibiting the JAK-STAT3 pathway
  Catalog No.:AP0063        Pubmed No.:37160212        PMCID:
  Details:
  Journal name:
• Rno_circRNA_006061 participates in apoptosis induced by formaldehyde via activating p38/ATF3 pathway
  Catalog No.:BD5010        Pubmed No.:37263556        PMCID:
  Details:
  Journal name:
• LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
  Catalog No.:BS3634        Pubmed No.:37160972        PMCID:
  Details:
  Journal name:
• LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
  Catalog No.:BS3633        Pubmed No.:37160972        PMCID:
  Details:
  Journal name:
• LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
  Catalog No.:BS1567        Pubmed No.:37160972        PMCID:
  Details:
  Journal name:
• LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
  Catalog No.:BS4853        Pubmed No.:37160972        PMCID:
  Details:
  Journal name:
• LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
  Catalog No.:BS4769        Pubmed No.:37160972        PMCID:
  Details:
  Journal name:
• LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
  Catalog No.:BS4653        Pubmed No.:37160972        PMCID:
  Details:
  Journal name:
• LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
  Catalog No.:BS4275        Pubmed No.:37160972        PMCID:
  Details:
  Journal name: